Real-World Evidence Jobs

182 open real-world evidence positions

Research & Development Clinical Development Clinical Operations Regulatory Affairs Quality Assurance Manufacturing Commercial Medical Affairs

Chef(fe) de Projets - Etudes RWE- CDI- H/F

Pierre Fabre

Posted 1mo ago

Hauts-de-Seine (92); Haute Garonne (31)

Full-time

Real-World EvidenceMID

Compensation Manager

Tempus

Posted 1mo ago

Chicago

$110K - $150K

Full-time

Real-World EvidenceMANAGER

H-1B · 1 FY23

Senior Director, RWE Lead in Inflammation Therapeutic Areas

Gilead Sciences

Posted 1mo ago

United States - California - Foster City; United States - New Jersey - Parsippany (Onsite - Hybrid Eligible)

$261K - $338K

Full-time

Viral Hepatitis COVID-19

Real-World EvidenceImmunologyExecutive

H-1B · 1 FY23

Senior Director, Epidemiology and RWE Oncology Franchise Lead

Gilead Sciences

Posted 1mo ago

Ireland - Dublin (Onsite Required)

Full-time

Viral Hepatitis COVID-19

Real-World EvidenceOncologyExecutive

H-1B · 1 FY23

Sr. Director, Epidemiology & RWE Analytics

Neurocrine Biosciences

Posted 1mo ago

US CA San Diego (On-Site)

$230K - $314K

Full-time

Tardive Dyskinesia

Real-World EvidenceNeurologyExecutive

H-1B · 1 FY23

Associate Director, Publications

Regeneron

Posted 1mo ago

SLEEPY HOLLOW; Warren

$157K - $257K

Full-time

Real-World EvidenceOncologyExecutive

H-1B · 1 FY23

Clinical Account Executive, Southern New Jersey

Tempus

Posted 1mo ago

Remote

$95K - $150K

Full-time

RemoteReal-World EvidenceOncologyExecutive

H-1B · 1 FY23

MRD Clinical Account Executive, Kansas City/Tulsa

Tempus

Posted 1mo ago

Remote

$166K - $398K

Full-time

RemoteReal-World EvidenceOncologyExecutive

H-1B · 1 FY23

Senior Director, US HEOR - Hampton, NJ

Celldex Therapeutics

Posted 1mo ago

Real-World EvidenceExecutive

Sr Director, Epidemiology and Real World Evidence Franchise Lead (Oncology)

Gilead Sciences

Posted 1mo ago

United States - California - Foster City (Onsite Required)

$261K - $338K

Full-time

Viral Hepatitis COVID-19

Real-World EvidenceOncologyExecutive

H-1B · 1 FY23

Clinical Terminologist

Tempus

Posted 1mo ago

Chicago; New York City

$67K - $95K

Full-time

Real-World EvidenceOncologyMID

H-1B · 1 FY23

Associate Director, Global Health Economics & Outcomes Research (RWE)

Madrigal Pharmaceuticals

Posted 1mo ago

Remote

$185K - $215K

Full-time

REZDIFFRA

Non-Alcoholic Steatohepatitis Liver Cirrhosis Liver Transplantation

RemoteReal-World EvidenceEndocrinologyExecutive

Senior Director, Epidemiology and RWE Franchise Lead (Oncology)

Gilead Sciences

Posted 1mo ago

United Kingdom - Uxbridge (Onsite Required)

Full-time

Viral Hepatitis COVID-19

Real-World EvidenceOncologyExecutive

H-1B · 1 FY23

Clinical Account Executive Oncology, Indianapolis

Tempus

Posted 1mo ago

Remote

$166K - $398K

Full-time

RemoteReal-World EvidenceOncologyExecutive

H-1B · 1 FY23

Clinical Account Executive Hereditary Cancer - Atlanta, GA

Tempus

Posted 1mo ago

Remote

$166K - $398K

Full-time

RemoteReal-World EvidenceOncologyExecutive

H-1B · 1 FY23

Associate Director, Global Health Economics Market Access - Biosurgery

Johnson & Johnson

Posted 1mo ago

Raritan, New Jersey, United States of America (Hybrid Work)

$137K - $236K

Full-time

Real-World EvidenceOncologyExecutive

H-1B · 1 FY23

Hunter Clinical Account Executive, HCT - St. Louis, MO

Tempus

Posted 1mo ago

Full-time

RemoteReal-World EvidenceGastroenterologyExecutive

H-1B · 1 FY23

Clinical Account Executive Hereditary Cancer - Richmond, VA

Tempus

Posted 1mo ago

Remote

$105K - $130K

Full-time

RemoteReal-World EvidenceOncologyExecutive

H-1B · 1 FY23

Associate Director, Health Economics & Reimbursement (HE&R)(on-site)

Abbott

Posted 1mo ago

United States - Minnesota - Plymouth; United States - California - Santa Clara

$129K - $259K

Full-time

Real-World EvidenceEndocrinologyExecutive

H-1B · 1 FY23

Director, Global Health Economics and Outcomes (GHEOR) - Immunology

Bristol Myers Squibb

Posted 1mo ago

Princeton - NJ - US

$212K - $257K

Full-time

Real-World EvidenceImmunologyExecutive

H-1B · 1 FY23